$3.110
-0.068 (-2.20%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CATX por análisis de gráficos similares
Alphio's CATX stock price prediction model matches the current Perspective Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.06 (-1.49%). The 1-week path is $3.26 (+4.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Perspective Therapeutics, Inc.?
Currently, CATX is not a strong buy due to its recent performance and financials. The stock is priced at $3.11, with a 5-day change of -5.76% and a 1-year change of -6.33%. While it has a gross margin of 100%, indicating potential for profitability, the company is still facing significant net losses, with a net income of -26,786,000 USD in Q2 2026. The forward P/E ratio is 25.71, which suggests that the stock may be overvalued given its current financial struggles. The main risk is its high volatility, with an implied volatility of 501.01%.
CATX cerró en $3.11 el Friday, tras bajar -2.20%
Perspective Therapeutics, Inc. (CATX) last closed at $3.11, losing -2.20%. These facts feed the 1-day and 1-week CATX price prediction above.
Factores de la previsión
Los factores de la previsión de Perspective Therapeutics, Inc. (CATX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CATX, ordenadas por similitud.
Análisis de estacionalidad de CATX
Historically the probability of a positive August return for CATX is 100.00%. August offers the highest probability of a positive month at 100.00%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CATX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $1.10 | $1.31 | $1.60 | -57.72% |
| Sep 2026 | $1.11 | $1.31 | $1.40 | -57.72% |
| Oct 2026 | $0.95 | $1.14 | $1.35 | -63.44% |
| Nov 2026 | $1.26 | $1.31 | $1.33 | -57.72% |
| Dec 2026 | $0.80 | $0.95 | $1.18 | -69.32% |
En 2026, se proyecta que Perspective Therapeutics, Inc. (CATX) oscile entre $0.80 y $1.60.
Previsión mensual de Perspective Therapeutics, Inc. para 2026
En Aug de 2026, se proyecta que Perspective Therapeutics, Inc. promedie $1.31, con un mínimo de $1.10 y un máximo de $1.60.
En Sep de 2026, se proyecta que Perspective Therapeutics, Inc. promedie $1.31, con un mínimo de $1.11 y un máximo de $1.40.
En Oct de 2026, se proyecta que Perspective Therapeutics, Inc. promedie $1.14, con un mínimo de $0.95 y un máximo de $1.35.
En Nov de 2026, se proyecta que Perspective Therapeutics, Inc. promedie $1.31, con un mínimo de $1.26 y un máximo de $1.33.
En Dec de 2026, se proyecta que Perspective Therapeutics, Inc. promedie $0.95, con un mínimo de $0.80 y un máximo de $1.18.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.